LDN 2019 Conference - Friday Morning Q&A (2019 Conference) (LDN, low dose naltrexone)
Presentations on the below and questions were asked in relation to:
- Mechanism of Action Stephen Dickson, BSC (hons) MRPharmS
- The Role of LDN in Cancer Management Prof Angus Dalgleish, MD
- LDN to Quell the Over-reactive Autoimmune Conditions Kicked up by Many of the Drugs in the Cancer World Today Nasha Winters, ND
- Infections in Cancer and Autoimmune Disorders Armin Schwarzbach, PhD, MD
- Autoimmune Hepatitis Paul Battle, PA-C